Q3 Revenue Tops Guidance at $184M, Up 20%; Q4 Outlook Set at $180-190M
KN sits 62% above its 52-week low of $20.57.
Summary
Knowles beat the top of its own Q3 revenue guidance with $184.0M, up 20% year over year from $152.9M, and non-GAAP diluted EPS of $0.38 landed at the high end of the guided range. Adjusted EBITDA rose to $48.3M, a 26.3% margin versus 25.8% a year ago, and operating cash flow jumped to $44.6M from $29.1M — a sharp reversal from the weak cash flow flagged in the Q2 10-Q filed July 28. Management guided Q4 revenue to $180-190M and non-GAAP EPS to $0.39-0.43, implying full-year 2026 revenue growth of about 16% at the midpoint. CEO Jeffrey Niew said the Precision Devices book-to-bill has stayed above one for eight straight quarters and expects 2027 to keep exceeding the revenue and adjusted EBITDA targets from the May 2025 Investor Day. The quarter's strength spans Medtech, Defense, Industrial and Electrification, with inventories up to $150.3M from $124.6M at year-end — worth checking on the call whether that build is pre-positioning for ramping design wins or a demand risk.
At the time of this announcement, KN was trading at $33.38 on NYSE in the Technology sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $20.57 to $42.93. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.